# Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression

> **NCT01670019** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 46 (actual)

## Conditions studied

- Major Depressive Disorder Without Psychotic Features

## Interventions

- **DRUG:** Asenapine 5-20 mg daily
- **DRUG:** Placebo 1-4 tablets daily

## Key facts

- **NCT ID:** NCT01670019
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-05
- **Final completion:** 2014-06
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2015-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01670019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01670019, "Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01670019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*